Study of 0.4% povidone-iodine nasal spray for SARS-CoV-2 : v

Evaluatig the virucidal efficacy of 0.4% povidone-iodine nasal spray against SARS-CoV-2 in the patients’ nasopharynx at 3 minutes, 4 hours after PVP-I exposure.

Related Keywords

Thailand , China , Japan , Guangdong , Jilin , Samut Sakhon , Thai , , Mahidol University , Guidelines For Reporting Parallel Group Randomised Trials , Sun Yat Sen University , Siriraj Hospital , Samut Sakhon Hospital , Siriraj Institutional Review Board , Ethic Committees , Thai Clinical Trials Registry , Precision System Science , Detection Kit , Fluorescence Probing , Updated Guidelines , Reporting Parallel Group Randomised , Commons Attribution , Viral Titers After , Baseline Value ,